Merit Medical Systems, Inc.
General ticker "MMSI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $5.5B (TTM average)
Merit Medical Systems, Inc. does not follow the US Stock Market performance with the rate: -1.8%.
Estimated limits based on current volatility of 1.4%: low 84.20$, high 86.56$
Factors to consider:
- Total employees count: 7400 (+6.5%) as of 2024
- China accounted for 11.0% of revenue in the fiscal year ended 2024-12-31
- US accounted for 59.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Geopolitical risks, Market competition, Litigation risks, Cybersecurity threats
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [85.38$, 117.81$]
- 2025-12-31 to 2026-12-31 estimated range: [93.34$, 128.06$]
Financial Metrics affecting the MMSI estimates:
- Negative: with PPE of 28.0 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 11.48
- Positive: 41.86 < Shareholder equity ratio, % of 57.03 <= 63.39
- Positive: -14.38 < Investing cash flow per share per price, % of -6.50
- Positive: Inventory ratio change, % of -1.05 <= -0.75
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.74
- Positive: 0.33 < Operating cash flow per share per price, % of 3.90
Short-term MMSI quotes
Long-term MMSI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,150.98MM | $1,257.37MM | $1,356.51MM |
| Operating Expenses | $1,063.42MM | $1,133.42MM | $1,200.82MM |
| Operating Income | $87.56MM | $123.94MM | $155.69MM |
| Non-Operating Income | $-4.93MM | $-11.86MM | $-5.70MM |
| Interest Expense | $6.34MM | $15.51MM | $31.22MM |
| R&D Expense | $82.18MM | $84.28MM | $87.47MM |
| Income(Loss) | $82.63MM | $112.09MM | $149.99MM |
| Taxes | $8.11MM | $17.68MM | $29.64MM |
| Profit(Loss)* | $74.52MM | $94.41MM | $120.36MM |
| Stockholders Equity | $1,144.40MM | $1,202.00MM | $1,379.36MM |
| Inventory | $265.99MM | $303.87MM | $306.06MM |
| Assets | $1,663.97MM | $2,325.24MM | $2,418.60MM |
| Operating Cash Flow | $114.29MM | $145.15MM | $220.80MM |
| Capital expenditure | $45.03MM | $36.70MM | $38.04MM |
| Investing Cash Flow | $-57.40MM | $-175.35MM | $-368.65MM |
| Financing Cash Flow | $-60.26MM | $559.27MM | $-60.01MM |
| Earnings Per Share** | $1.31 | $1.64 | $2.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.